ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

FACTOR VIII DE COAGULARE

Active substance (INN) · ATC B02BD02 · 27 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
BD01D HEMOFILIA A si B si BOALA VON WILLEBRAND In force mentioned in the text C2-P6.1 NO
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
BERIATE 1000 UIPULB.+SOLV. PT. SOL. INJ./PERF.1000UICSL BEHRING GMBH - GERMANIAB02BD02PR
BERIATE 2000 UIPULB.+SOLV. PT. SOL. INJ./PERF.2000UICSL BEHRING GMBH - GERMANIAB02BD02PR
BERIATE 250 UIPULB.+SOLV. PT. SOL. INJ./PERF.250UICSL BEHRING GMBH - GERMANIAB02BD02PR
BERIATE 500 UIPULB.+SOLV. PT. SOL. INJ./PERF.500UICSL BEHRING GMBH - GERMANIAB02BD02PR
EMOCLOT 500 UIPULB.+SOLV. SOL. PERF.500 UIKEDRION S.P.A. - ITALIAB02BD02PR
FANHDI 1000 UIPULB.+SOLV. PT. SOL. INJ.1000UIINSTITUTO GRIFOLS S.A. - SPANIAB02BD02PR
FANHDI 250 UIPULB.+SOLV. PT. SOL. INJ.250UIINSTITUTO GRIFOLS S.A. - SPANIAB02BD02PR
FANHDI 500 UIPULB.+SOLV. PT. SOL. INJ.500UIINSTITUTO GRIFOLS S.A. - SPANIAB02BD02PR
HAEMATE P 1000UI FVIII/2400 UI FVWPULB.+SOLV. PT. SOL. INJ. SAU PERF.1000UIFVIII/2400UIFVWCSL BEHRING GMBH - GERMANIAB02BD06PRF
HAEMATE P 250UI FVIII/600 UI FVWPULB.+SOLV. PT. SOL. INJ. SAU PERF.250UIFVIII/600UIFVWCSL BEHRING GMBH - GERMANIAB02BD06PRF
HAEMATE P 500UI FVIII/1200 UI FVWPULB.+SOLV. PT. SOL. INJ. SAU PERF.500UIFVIII/1200UIFVWCSL BEHRING GMBH - GERMANIAB02BD06PRF
HAEMOCTIN SDH 1000PULB.+SOLV. PT. SOL. INJ.200UI/mlBIOTEST PHARMA GMBH - GERMANIAB02BD02PR
HAEMOCTIN SDH 250PULB.+SOLV. PT. SOL. INJ.100UI/mlBIOTEST PHARMA GMBH - GERMANIAB02BD02PR
HAEMOCTIN SDH 500PULB.+SOLV. PT. SOL. INJ.100UI/mlBIOTEST PHARMA GMBH - GERMANIAB02BD02PR
IMMUNATE 1000 UI FVIII/750 UI FVWPULB.+SOLV. PT. SOL. INJ.1000 UI /750 UIBAXALTA INNOVATIONS GMBH - AUSTRIAB02BD06PR
IMMUNATE 250 UI FVIII/190 UI FVWPULB.+SOLV. PT. SOL. INJ.250 UI /190 UIBAXALTA INNOVATIONS GMBH - AUSTRIAB02BD06PR
IMMUNATE 500 UI FVIII/375 UI FVWPULB.+SOLV. PT. SOL. INJ.500 UI /375 UIBAXALTA INNOVATIONS GMBH - AUSTRIAB02BD06PR
NUWIQ 1000UIPULB.+SOLV. PT. SOL. INJ.1000 UIOCTAPHARMA AB - SUEDIAB02BD02PR
NUWIQ 2000UIPULB.+SOLV. PT. SOL. INJ.2000 UIOCTAPHARMA AB - SUEDIAB02BD02PR
NUWIQ 250UIPULB.+SOLV. PT. SOL. INJ.250 UIOCTAPHARMA AB - SUEDIAB02BD02PR
NUWIQ 500UIPULB.+SOLV. PT. SOL. INJ.500 UIOCTAPHARMA AB - SUEDIAB02BD02PR
OCTANATE 100 UI/mlPULB.+SOLV. PT. SOL. INJ.100UI/mlOCTAPHARMA (IP) SPRL - BELGIAB02BD02PR
OCTANATE 50 UI/mlPULB.+SOLV. PT. SOL. INJ.50UI/mlOCTAPHARMA (IP) SPRL - BELGIAB02BD02PR
OCTANATE LV 100 UI/mlPULB.+SOLV. PT. SOL. INJ.100UI/mlOCTAPHARMA (IP) SPRL - BELGIAB02BD02PR
OCTANATE LV 200 UI/mlPULB.+SOLV. PT. SOL. INJ.200UI/mlOCTAPHARMA (IP) SPRL - BELGIAB02BD02PR
WILATE 1000 1000 UI FVW/1000 UI FVIIIPULB.+SOLV. PT. SOL. INJ.1000 UI FVW/1000 UI FVIIIOCTAPHARMA (IP) SPRL - BELGIAB02BD06PR
WILATE 500 500 UI FVW/500 UI FVIIIPULB.+SOLV. PT. SOL. INJ.500 UI FVW/500 UI FVIIIOCTAPHARMA (IP) SPRL - BELGIAB02BD06PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.